Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Garo Armen Insider Profile
32 Followers
Garo Armen, Chairman and CEO, Director at Agenus, holds 2.54M shares in Agenus (Ticker: AGEN), holds 1.87M shares in MiNK Therapeutics (Ticker: INKT), holds ― shares in Protagenic Therapeutics (Ticker: PTIX).
Profitable Transactions
5 out of 7 Profitable Transactions
Average Return
+18.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Garo Armen holds in companies
Most Profitable Insider Trade
The most profitable trade made by Garo Armen
Garo Armen's Trading History
Agenus
Apr 08, 2024
Chairman and CEO, Director
Uninformative Buy
16.35K
$13.72M
MiNK Therapeutics
May 05, 2023
Director
Informative Sell
94.00K
$1.71M
Protagenic Therapeutics
―
Executive Chairman, Director, Ten Percent Owner
―
―
List of latest transactions for each holding click on a transaction to see Garo Armen's performance on stock
You May Also Like
Garo Armen insider profile FAQ
What is the percentage of profitable transactions made by Garo Armen?
The percentage of profitable transactions made by Garo Armen is 71%.
What is the average return per transaction made by Garo Armen?
The average return per transaction made by Garo Armen is 18.80%.
What stocks does Garo Armen hold?
Garo Armen holds: AGEN, INKT, PTIX stocks.
What was Garo Armen’s latest transaction?
Garo Armen latest transaction was an Uninformative Buy of $16.35K.
What was Garo Armen's most profitable transaction?
Garo Armen’s most profitable transaction was an Informative Buy of AGEN stock on September 29, 2015. The return on the trade was 55.00%.
What is Garo Armen's role in Agenus?
Garo Armen's role in Agenus is Chairman and CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.